Sanofi (SAN.PA)
| Previous close | 78.23 |
| Open | 76.96 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 76.70 - 77.90 |
| 52-week range | 67.65 - 95.82 |
| Volume | 2,775,932 |
| Avg. volume | 1,805,536 |
| Market cap | 97.203B |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 8.83 |
| EPS (TTM) | 8.77 |
| Earnings date | 29 Oct 2020 |
| Forward dividend & yield | 3.15 (4.03%) |
| Ex-dividend date | 04 May 2020 |
| 1y target est | 82.62 |
- Motley Fool
Sanofi (SNY) Q3 2020 Earnings Call Transcript
SNY earnings call for the period ending September 30, 2020.
- Zacks
Pharma Stock Roundup: Q3 Earnings, Resumption of AZN/JNJ Coronavirus Vaccine Study
Eli Lilly (LLY), Merck (MRK), Pfizer (PFE), Novartis (NVS) and others release Q3 results
- Reuters
Activists urge 'Big Pharma' to be transparent on COVID-19 vaccine costs
Activists called on pharmaceutical companies on Thursday to be transparent about the costs and terms of providing COVID-19 vaccines, saying they must be available and affordable for all. French drugmaker Sanofi <SASY.PA> and Britain's GlaxoSmithKline <GSK.L> said on Wednesday they would supply 200 million doses of their COVID-19 candidate vaccine to the global COVAX vaccine facility backed by the World Health Organization (WHO) and the GAVI vaccine alliance. Medecins Sans Frontieres (Doctors Without Borders) demanded the two companies provide details around price, supply and distribution of any vaccine proven safe and effective.
